Abstract:Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other; the comorbidity of these brain disorders in aging individuals represents a significant challenge in basic research and clinical practice. The similarities and differences between stroke and AD in terms of pathogenesis and pathophysiology, however, have rarely been comparably reviewed. Here, we discuss the research background and recent progresses that are important and informative for the comorbidity of stroke and late-onset AD and related dementia (ADRD). Glutamatergic NMDA receptor (NMDAR) activity and NMDAR-mediated Ca2+ influx are essential for neuronal function and cell survival. An ischemic insult, however, can cause rapid increases in glutamate concentration and excessive activation of NMDARs, leading to swift Ca2+ overload in neuronal cells and acute excitotoxicity within hours and days. On the other hand, mild upregulation of NMDAR activity, commonly seen in AD animal models and patients, is not immediately cytotoxic. Sustained NMDAR hyperactivity and Ca2+ dysregulation lasting from months to years, nevertheless, can be pathogenic for slowly evolving events, i.e. degenerative excitotoxicity, in the development of AD/ADRD. Specifically, Ca2+ influx mediated by extrasynaptic NMDARs (eNMDARs) and a downstream pathway mediated by transient receptor potential cation channel subfamily M member (TRPM) are primarily responsible for excitotoxicity. On the other hand, the NMDAR subunit GluN3A plays a "gatekeeper" role in NMDAR activity and a neuroprotective role against both acute and chronic excitotoxicity. Thus, ischemic stroke and AD share an NMDAR- and Ca2+-mediated pathogenic mechanism that provides a common receptor target for preventive and possibly disease-modifying therapies. Memantine (MEM) preferentially blocks eNMDARs and was approved by the Federal Drug Administration (FDA) for symptomatic treatment of moderate-to-severe AD with variable efficacy. According to the pathogenic role of eNMDARs, it is conceivable that MEM and other eNMDAR antagonists should be administered much earlier, preferably during the presymptomatic phases of AD/ADRD. This anti-AD treatment could simultaneously serve as a preconditioning strategy against stroke that attacks ≥ 50% of AD patients. Future research on the regulation of NMDARs, enduring control of eNMDARs, Ca2+ homeostasis, and downstream events will provide a promising opportunity to understand and treat the comorbidity of AD/ADRD and stroke.

Glutamate Receptor-Independent Calcium Toxicity Pathways in Acute Ischemic Brain Injury

Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury

Excessive Na+/H+ Exchange in Disruption of Dendritic Na+ and Ca2+ Homeostasis and Mitochondrial Dysfunction Following in Vitro Ischemia

Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke

Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity

Intracellular Zn2+ Accumulation Contributes To Synaptic Failure, Mitochondrial Depolarization, And Cell Death In An Acute Slice Oxygen-Glucose Deprivation Model Of Ischemia

Glutamate as a co-agonist for acid-sensing ion channels to aggravate ischemic brain damage

Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury

Effect of Acid-sensing Ion Channels in Ischemic Brain Injury

Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer's disease

ASICs Aggravate Acidosis-Induced Injuries During Ischemic Reperfusion

Astrocytic Ca2+ Waves Mediate Activation of Extrasynaptic NMDA Receptors in Hippocampal Neurons to Aggravate Brain Damage During Ischemia

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

Excitotoxic Storms of Ischemic Stroke: A Non-neuronal Perspective

Contribution of TRPC Channels in Neuronal Excitotoxicity Associated With Neurodegenerative Disease and Ischemic Stroke

The underlying mechanism of calcium toxicity-induced autophagic cell death and lysosomal degradation in early stage of cerebral ischemia

Mechanisms of Brain Injury after Global Cerebral Ischemia

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

Inhibitory Mechanisms in Cerebral Ischemia: a Brief Review

Kainic acid-mediated excitotoxicity as a model for neurodegeneration

Inhibition of Intracellular Proton-Sensitive Ca2+-permeable TRPV3 Channels Protects Against Ischemic Brain Injury.